Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (47)
Miteshkumar Rajaram Maurya, Renuka Munshi, Sachin Bhausaheb Zambare & Sanket Thakur. 2023. Immunosuppression and Immunomodulation. Immunosuppression and Immunomodulation.
Veronika Schmidt, Sophie Lalevée, Stephan Traidl, Milad Ameri, Reihane Ziadlou, Saskia Ingen‐Housz‐Oro, Caroline Barau, Nicolas de Prost, Mirjam Nägeli, Yasutaka Mitamura, Barbara Meier‐Schiesser, Alexander A. Navarini, Lars E. French, Emmanuel Contassot & Marie‐Charlotte Brüggen. (2022) Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: Diverse effects on systemic inflammation. Allergy 78:5, pages 1280-1291.
Crossref
Crossref
Maja Mockenhaupt. (2023) Schwere kutane Arzneimittelreaktionen bei KindernSevere cutaneous drug reactions in children. Monatsschrift Kinderheilkunde 171:5, pages 439-451.
Crossref
Crossref
Shankargouda Patil, Shazia mustaq, Jagadish Hosmani, Zafar Ali Khan, Pradeep Kumar Yadalam, Zeeshan Heera Ahmed, Shilpa Bhandi & Kamran Habib Awan. (2023) Advancement in therapeutic strategies for immune-mediated oral diseases. Disease-a-Month 69:1, pages 101352.
Crossref
Crossref
Rawan Hubail, Layal Alnajjar & Ameen Al Awadhi. (2022) Cephradine-Induced Toxic Epidermal Necrolysis: A Case Report of Treatment With Etanercept. Cureus.
Crossref
Crossref
Ana Maria Copaescu, Moshe Ben-Shoshan & Jason A. Trubiano. (2022) Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions. Frontiers in Medicine 9.
Crossref
Crossref
Hua-Ching Chang, Tsung-Jen Wang, Ming-Hsiu Lin & Ting-Jui Chen. (2022) A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis. Biomedicines 10:9, pages 2105.
Crossref
Crossref
Michele L. Ramien, Danny Mansour & Neil H. Shear. (2022) Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens–Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN. Pediatric Drugs 24:4, pages 307-319.
Crossref
Crossref
Lu Yang, Yan-Hong Shou, Feng Li, Xiao-Hua Zhu, Yong-Sheng Yang & Jin-Hua Xu. (2022) Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China. Frontiers in Pharmacology 12.
Crossref
Crossref
Yaseen Hussain & Haroon Khan. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
726
740
.
Khosrow S Houschyar, Christian Tapking, Mimi R Borrelli, Behrus Puladi, Mark Ooms, Christoph Wallner, Dominik Duscher, Dominik Pförringer, Susanne Rein, Georg Reumuth, Torsten Schulz, Ina Nietzschmann, Zeshaan N Maan, Gerrit Grieb, Wolfgang G Philipp-Dormston, Ludwik K Branski, Frank Siemers, Marcus Lehnhardt, Laurenz Schmitt & Amir S Yazdi. (2021) Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. Journal of Wound Care 30:12, pages 1012-1019.
Crossref
Crossref
Jesus Antonio Ocejo Gallegos & Surabhi Amar. (2021) Stevens-Johnson syndrome/toxic epidermal necrolysis overlap caused by enzalutamide in patient with metastatic prostate cancer. BMJ Case Reports 14:11, pages e242319.
Crossref
Crossref
Julian Wier, Alexandra Lacey, Haig Yenikomshian & Justin Gillenwater. (2021) A Fatal Case of Toxic Epidermal Necrolysis Combined With Vanishing Bile Duct Syndrome and Hemophagocytic Lymphohistiocytosis. Journal of Burn Care & Research 42:5, pages 1043-1046.
Crossref
Crossref
Robert Frantz, Simo Huang, Abhirup Are & Kiran Motaparthi. (2021) Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management. Medicina 57:9, pages 895.
Crossref
Crossref
Andrej Cokan, Vida Gavrić Gavrić Lovrec & Iztok Takač. (2021) A Case of Stevens–Johnson Syndrome in Recurrent Late-Stage Ovarian Cancer Patient after Management of Chronic Pain with Elastomeric Pump. Current Oncology 28:4, pages 2928-2932.
Crossref
Crossref
Khosrow S Houschyar, Christian Tapking, Mimi R Borrelli, Ina Nietzschmann, Behrus Puladi, Mark Ooms, Susanne Rein, Madeline Houschyar, Dominik Duscher, Zeshaan N Maan, Georg Reumuth, Ludwik K Branski, Ali Modabber, David Kluwig, Laurenz Schmitt, Wolfgang G Philipp-Dormston, Amir S Yazdi & Frank Siemers. (2021) Stevens–Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit. Journal of Wound Care 30:6, pages 492-496.
Crossref
Crossref
Argyrios Chronopoulos, Maja Mockenhaupt & Uwe Pleyer. (2021) Okuläre Beteiligung bei Stevens-Johnson-Syndrom und toxisch epidermaler NekrolyseOcular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis. Der Ophthalmologe 118:5, pages 519-532.
Crossref
Crossref
Tejas K. Patel, Parvati B. Patel & Sejal Thakkar. (2021) Comparison of effectiveness of interventions in reducing mortality in patients of toxic epidermal necrolysis: A network meta-analysis. Indian Journal of Dermatology, Venereology and Leprology 87, pages 628-644.
Crossref
Crossref
Paul V. Viscuse, Mario L. Marques-Piubelli, Meghan M. Heberton, Edwin Roger Parra, Amishi Y. Shah, Arlene Siefker-Radtke, Jianjun Gao, Sangeeta Goswami, Doina Ivan, Jonathan L. Curry & Matthew T. Campbell. (2021) Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction. Frontiers in Oncology 11.
Crossref
Crossref
Chunxia He, Xiaoyan Si, Li Zhang, Yan Xu & Tao Qu. (2021) Immune checkpoint inhibitor–related epidermal necrolysis: A rare condition with poor prognosis. European Journal of Cancer 145, pages 194-196.
Crossref
Crossref
Tsung-Yu Tsai, I-Hsin Huang, Yuan-Chen Chao, Hua Li, Tyng-Shiuan Hsieh, Hsiao-Han Wang, Yu-Ting Huang, Chun-Yuan Chen, Ying-Chih Cheng, Po-Hsiu Kuo, Yu-Chen Huang & Yu-Kang Tu. (2021) Treating toxic epidermal necrolysis with systemic immunomodulating therapies: A systematic review and network meta-analysis. Journal of the American Academy of Dermatology 84:2, pages 390-397.
Crossref
Crossref
María Fernanda Meza-Corso & Cesar González-Ardila. (2021) Actualización en el tratamiento de las reacciones adversas cutáneas graves a los medicamentos. Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica 28:4, pages 340-351.
Crossref
Crossref
Manisha Balai, Manju Meena, Asit Mittal, LalitKumar Gupta, AshokKumar Khare & Sharad Mehta. (2021) Cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis: Experience from a tertiary care centre of South Rajasthan. Indian Dermatology Online Journal 12:1, pages 116.
Crossref
Crossref
Leangelo N. Hall, Swapna S. Shanbhag, Ramy Rashad, James Chodosh & Hajirah N. Saeed. (2021) The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease. The Ocular Surface 19, pages 128-132.
Crossref
Crossref
Maja Mockenhaupt. 2021. Diseases of the Oral Mucosa. Diseases of the Oral Mucosa
409
422
.
Joanna Harp & Alina Markova. 2021. Oncologic Emergency Medicine. Oncologic Emergency Medicine
451
469
.
Maja Mockenhaupt. 2022. Allergic Diseases – From Basic Mechanisms to Comprehensive Management and Prevention. Allergic Diseases – From Basic Mechanisms to Comprehensive Management and Prevention
195
212
.
Ivorie Coleman, Gabriel Ruiz, Sumir Brahmbhatt & Lindsay Ackerman. (2020) Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report. Journal of Medical Case Reports 14:1.
Crossref
Crossref
Burçin Cansu Bozca, Ceren Memiş Irican & Ayşe Akman Karakaş. (2020) Three toxic epidermal necrolysis cases treated with cyclosporine and a review of the literature. Dermatologic Therapy 33:6.
Crossref
Crossref
Megan H. Noe & Robert G. Micheletti. (2020) Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis. Clinics in Dermatology 38:6, pages 607-612.
Crossref
Crossref
E.C. Kuijper, L.E. French, C.P. Tensen, M.H. Vermeer & J.N. Bouwes Bavinck. (2020) Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN). Journal of the European Academy of Dermatology and Venereology 34:9, pages 1957-1971.
Crossref
Crossref
Subhra Sankar Sen, Abheek Sil, Uddalak Chakraborty & Atanu Chandra. (2020) Stevens-Johnson syndrome-toxic epidermal necrolysis: a fatal cutaneous adverse reaction to oral acyclovir. BMJ Case Reports 13:8, pages e238555.
Crossref
Crossref
Lu Yang, Yan-hong Shou, Feng Li, Xiao-hua Zhu, Yong-sheng Yang & Jin-hua Xu. (2020) Retrospective study of 213 cases of Stevens–Johnson syndrome and toxic epidermal necrolysis from China. Burns 46:4, pages 959-969.
Crossref
Crossref
Christopher H. Pham, T. Justin Gillenwater & Warren L. Garner. (2020) Re: Combination therapy for Toxic Epidermal Necrolysis: It is time for anti-TNFa biologics comparison. Burns 46:1, pages 245-246.
Crossref
Crossref
Akito Hasegawa & Riichiro Abe. (2020) Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis. F1000Research 9, pages 612.
Crossref
Crossref
Amitava Dasgupta & Matthew D. Krasowski. 2020. Therapeutic Drug Monitoring Data. Therapeutic Drug Monitoring Data
271
307
.
Frane Banovic. 2020. Feline Dermatology. Feline Dermatology
511
530
.
Katherine Menson & Garth W. Garrison. 2020. Evidence-Based Critical Care. Evidence-Based Critical Care
773
777
.
Jennifer L. Coias, Laila F. Abbas & Adela R. Cardones. (2019) Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: a Review and Update. Current Dermatology Reports 8:4, pages 219-233.
Crossref
Crossref
Christopher H. Pham, T. Justin Gillenwater, Eric Nagengast, Meghan C. McCullough, David H. Peng & Warren L. Garner. (2019) Combination therapy: Etanercept and intravenous immunoglobulin for the acute treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis. Burns 45:7, pages 1634-1638.
Crossref
Crossref
Amy J. Zhang, Rachel M. Nygaard, Frederick W. Endorf & Sara A. Hylwa. (2019) Stevens‐Johnson syndrome and toxic epidermal necrolysis: retrospective review of 10‐year experience. International Journal of Dermatology 58:9, pages 1069-1077.
Crossref
Crossref
Knut Brockow & Wolfgang Pfützner. (2019) Cutaneous drug hypersensitivity: developments and controversies. Current Opinion in Allergy & Clinical Immunology 19:4, pages 308-318.
Crossref
Crossref
Michael R. Ardern-Jones & Maja Mockenhaupt. (2019) Making a diagnosis in severe cutaneous drug hypersensitivity reactions. Current Opinion in Allergy & Clinical Immunology 19:4, pages 283-293.
Crossref
Crossref
Nikki Canter & Lane Smith. (2019) Incomplete Stevens-Johnson Syndrome Caused by Sulfonamide Antimicrobial Exposure. Clinical Practice and Cases in Emergency Medicine 3:3, pages 240-242.
Crossref
Crossref
Xiaolan Zheng, Peng Yue, Lei Liu, Changqing Tang, Fan Ma, Yi Zhang, Chuan Wang, Hongyu Duan, Kaiyu Zhou, Yimin Hua, Gang Wu & Yifei Li. (2019) Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis. PLOS ONE 14:5, pages e0217274.
Crossref
Crossref
Keshavamurthy Vinay, Akanksha Kaushik, Muthu Sendhil Kumaran & Davinder Parsad. (2019) Intravenous cyclosporine in treatment of Stevens–Johnson syndrome/toxic epidermal necrolysis: A case series. Dermatologic Therapy, pages e12957.
Crossref
Crossref
Victoria López-GómezRamón Yarza, Héctor Muñoz-González, Enrique RevillaSantos EnrechOlga González-VallePablo TolosaEva Ciruelos. (2019) Ribociclib-Related Stevens–Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review. Journal of Breast Cancer 22:4, pages 661.
Crossref
Crossref